| Prev Close | 70.01 |
| Day Low/High | 69.08 / 70.52 |
| 52 Wk Low/High | 57.68 / 96.38 |
| Avg Volume | 1.18M |
| Exchange | NASDAQ |
| Shares Outstanding | 86.37M |
| Market Cap | 6.05B |
| EPS | -0.80 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Apple Watch Is on Its Way to Becoming a $6 Billion Business, but Is That Really Enough?
After a slump early last year, the smartwatch's sales have been rebounding.
New Study Shows Adults With Type 1 And Type 2 Diabetes On Multiple Daily Injections (MDI) Benefit From CGM
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is presenting important clinical data for patients with type 1 and type 2 diabetes, at the American Diabetes...
Dexcom To Add Ambulatory Glucose Profile (AGP) To Dexcom CLARITY®
DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile (AGP) into its Dexcom CLARITY software.
DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices
DexCom's app tracks glucose levels for people with diabetes.
DexCom Announces FDA Approval Of G5 Mobile App For Android Devices
DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android...
Apple Watch Appears on Its Way to Becoming a $6 Billion Business
After a slump early last year, the smartwatch's sales have been rebounding. New features unveiled at Apple's WWDC conference could aid its momentum later this year.
DexCom Stock Surging on Apple Watch Partnership
Apple will release a new Bluetooth API for the Apple Watch.
Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)
First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.
DexCom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President & Chief Executive Officer, will present on...
DexCom Prices Offering Of $350 Million Of 0.75% Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today the pricing of its offering of $350 million aggregate principal amount of 0.
DexCom Announces Proposed Offering Of $300 Million Of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $300 million aggregate principal amount of Convertible Senior Notes due 2022 (the "notes") in...
DexCom, Inc. Reports First Quarter 2017 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2017.
10 Things We Learned From Our Daily Facebook Show With Jim Cramer
A few important takeaways from our daily Facebook show with Jim Cramer.
Jim Cramer: Report of Apple's Diabetes Test Isn't a Reason to Own the Stock
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said reports of Apple developing a diabetes testing product is not a reason to own the stock.
Trader's Daily Notebook: Worried About Volume? Just Let It Go
Old-line momentum favorites fare well.
Trader's Daily Notebook: Worried About Volume? Just Let It Go
Old-line momentum favorites fare well.
Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For All People With Diabetes On Intensive Insulin Therapy
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce that the U.
DexCom Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 At 4:30 P.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2017 financial results after market close on Tuesday, May 2, 2017.
When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)
Jim Cramer says economic fundamentals remain strong and this market's rallying with relief at Fed's anticipated rate hike.
DexCom Appoints Richard Collins To Board Of Directors
DexCom, Inc. (Nasdaq: DXCM) today announced that Richard Collins has been appointed to the company's Board of Directors, effective March 9, 2017.
DexCom, Inc. Reports Fourth Quarter And Fiscal Year 2016 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2016.
DexCom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...
DexCom Is a Great Healthcare Stock to Buy Now
The continuous glucose monitor maker is an excellent growth opportunity.
Alphabet's Verily Sells Stake to Temasek in Bid for Overseas Expansion
The sale of the $800M stake to Temasek comes as the Google parent scales back some of its other big bets.
DexCom Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017 At 4:30 P.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2016 financial results after market close on Tuesday, February 28, 2017.
The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)
Don't worry about a little selloff, says Jim Cramer. The data and earnings signal an improving economy.
Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns
These companies show signs of a change of direction.
